Solventum Corporation earnings overview

Solventum Corporation

Solventum's first-quarter FY2026 results beat consensus on both lines, with EPS of $1.48 (vs. $1.35 estimated) and revenue of $2.01 billion (vs. $1.97 billion estimated). The beat was underpinned by approximately 4% normalized organic growth, 80 basis points of operating margin expansion, and early contribution from the Acera acquisition. Management maintained full-year guidance and signaled EPS would trend toward the high end of the $6.40-$6.60 range. The 3M separation is advancing with 50% of transition service agreements extinguished and ERP migrations underway, though timing is expected to shift over $100 million of sales into Q2 with a reverse effect in Q3. The stock has drifted approximately 16% higher since the report, suggesting the market is rewarding the operational progress and capital return.